By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Oxygen Biotherapeutics, Inc. 

(Formerly Synthetic Blood International, Inc.)
3189 Airway Avenue, Building C
Costa Mesa  California  92626  U.S.A.
Phone: 800-809-6054 Fax: 714-427-6361


SEARCH JOBS








Company News
Oxygen Biotherapeutics, Inc. (OXBT) Announces Fiscal Year 2014 Financial Results 7/29/2014 9:42:20 AM
Oxygen Biotherapeutics, Inc. (OXBT) To Announce Fourth Quarter And Fiscal Year 2014 Financial Results On July 29, 2014 7/23/2014 1:33:43 PM
Oxygen Biotherapeutics, Inc. (OXBT) Release: Recent Scientific Publications Highlight Potential Benefits Of Levosimendan In Cardiac Surgery And Additional Critical Care Conditions 7/9/2014 10:54:48 AM
Oxygen Biotherapeutics, Inc. (OXBT) Announces Formation Of Steering Committee For Phase 3 LEVO-CTS Trial Of Levosimendan 6/2/2014 10:55:01 AM
Oxygen Biotherapeutics, Inc. (OXBT) Late-Stage Clinical Trials Could Bode Well For Shareholders Analyst Reports 5/12/2014 8:26:53 AM
Oxygen Biotherapeutics, Inc. (OXBT) Analyst Report: Positive FDA Catalyst Has Emerging Biopharmaceutical Player Back In the Clinical Trial Business 4/21/2014 9:02:37 AM
Oxygen Biotherapeutics, Inc. (OXBT) Announces The Appointment Of Industry Veteran Gerald Proehl To Its Board Of Directors 4/7/2014 7:30:01 AM
Oxygen Biotherapeutics, Inc. (OXBT) Announces The Appointment Of Industry Veteran Gerald Proehl To Its Board Of Directors 4/4/2014 7:10:41 AM
FDA Lifts Clinical Hold On Oxygen Biotherapeutics, Inc. (OXBT)'s Program 3/31/2014 7:53:03 AM
Oxygen Biotherapeutics, Inc. (OXBT) Announces Proposed Public Offering 3/18/2014 9:11:15 AM
12345678910...
//-->